133731-61-0Relevant articles and documents
HETEROCYCLIC COMPOUND AND USE THEREOF
-
, (2021/04/02)
Provided is a heterocyclic compound that can have an antagonistic action on an NMD A receptor containing the NR2B subunit and that is expected to be useful as a prophylactic or therapeutic agent for depression, bipolar disorder, migraine, pain, peripheral symptoms of dementia and the like. A compound represented by the formula (I), wherein each symbol is as defined in the DESCRIPTION, or a salt thereof.
MORPHOLINE CARBOXAMIDE PROKINETICIN RECEPTOR ANTAGONISTS
-
Page/Page column 36, (2008/06/13)
The present invention is directed to morpholine carboxamide compounds which are antagonists of prokineticin receptors, in particular antagonists of prokineticin 2 receptors, and which are useful in the treatment or prevention of neurological and psychiatr